These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 7516861)
1. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Plosker GL; McTavish D Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861 [TBL] [Abstract][Full Text] [Related]
2. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience. Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293 [TBL] [Abstract][Full Text] [Related]
3. Sumatriptan. An updated review of its use in migraine. Perry CM; Markham A Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601 [TBL] [Abstract][Full Text] [Related]
4. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Dechant KL; Clissold SP Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152 [TBL] [Abstract][Full Text] [Related]
5. Rizatriptan: a review of its efficacy in the management of migraine. Dooley M; Faulds D Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439 [TBL] [Abstract][Full Text] [Related]
6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
7. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group. Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
9. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
11. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
14. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine. Fullerton T; Gengo FM Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244 [TBL] [Abstract][Full Text] [Related]
15. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799 [TBL] [Abstract][Full Text] [Related]
16. Almotriptan: a review of its use in migraine. Keam SJ; Goa KL; Figgitt DP Drugs; 2002; 62(2):387-414. PubMed ID: 11817980 [TBL] [Abstract][Full Text] [Related]